Hispanic stroke patients admitted to hospitals in the border states of California, Arizona, New Mexico and Texas were less likely than non-Hispanics in the same border states to receive clot-busting drugs and more likely to die, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Researchers analyzed stroke care for Hispanic and non-Hispanic patients according to demographics and clinical characteristics in states bordering Mexico and states not on the Mexican border. They found:
Story Source:
Materials provided by American Heart Association. Note: Content may be edited for style and length.
Cite This Page: